Latest Ipratropium/salbutamol Stories
An over-the-counter asthma inhaler is to be banned beginning next year because federal health officials said it produces carbon gas that is harmful to the environment.
WALTHAM, Mass., April 26 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite increased competition from several emerging agents, GlaxoSmithKline's Advair will remain surveyed pulmonologists' and primary care physicians' (PCPs) favored fixed-dose long-acting beta2 agonist (LABA)/inhaled corticosteroid (ICS) combination inhaler through 2013 for the treatment of asthma and chronic obstructive...
RIDGEFIELD, Conn., April 13 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S.
SILVER SPRING, Md., April 13 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S.
PITTSBURGH, March 18 /PRNewswire/ -- ChemImage, a world leader in chemical imaging products and services, will present the results of an ingredient-specific particle sizing (ISPST) study on a combination Metered Dose Inhaler product at Respiratory Drug Delivery (RDD) 2010 (www.rddonline.com).
NAPA, Calif., Sept. 17 /PRNewswire-FirstCall/ -- Dey, L.P. today announced that it has settled a lawsuit brought against it and other companies by the State of Utah in October 2005 pertaining to Medicaid reimbursements paid by the state to pharmacists and other healthcare providers.
Federal officials are warming consumers not to use certain respiratory medications purchased after Sept. 8, produced by Dey L.P., a subsidiary of Mylan Inc. The U.S.
PITTSBURGH, Jan. 12 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Dey L.P. has been issued several additional U.S. patents protecting the company's Perforomist(R) Inhalation Solution, a chronic obstructive pulmonary disease (COPD) treatment. U.S.
NAPA, Calif., Jan. 7 /PRNewswire/ -- Dey, L.P. today announced that it has settled a lawsuit brought against it and other companies by the State of Mississippi in October 2005 pertaining to Medicaid reimbursements paid by the state to pharmacists and other healthcare providers.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.